Free Trial

Agilon Health (NYSE:AGL) Trading Up 9.5% - What's Next?

Agilon Health logo with Medical background

Key Points

  • Agilon Health's stock rose 9.5% in mid-day trading, reaching a high of $1.22, despite a significant decrease in trading volume compared to average levels.
  • Wall Street analysts are divided on Agilon Health, with targets ranging from as low as $1.10 to as high as $5.00, resulting in a consensus rating of "Hold" and an average target price of $3.58.
  • Recently, several institutional investors have increased their stakes in Agilon Health, indicating growing interest from hedge funds and investors in the company.
  • Looking to export and analyze Agilon Health data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Agilon Health, Inc. (NYSE:AGL - Get Free Report) shares shot up 9.5% during mid-day trading on Monday . The company traded as high as $1.20 and last traded at $1.22. 2,169,071 shares traded hands during trading, a decline of 70% from the average session volume of 7,194,488 shares. The stock had previously closed at $1.11.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on AGL. Benchmark dropped their price target on shares of Agilon Health from $4.00 to $1.50 and set a "buy" rating on the stock in a research report on Wednesday, August 6th. Citigroup upgraded Agilon Health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $3.25 to $5.00 in a report on Friday, April 25th. Barclays lowered their target price on shares of Agilon Health from $3.00 to $1.50 and set an "underweight" rating on the stock in a report on Wednesday, August 6th. Evercore ISI dropped their price objective on Agilon Health from $5.00 to $3.00 and set an "in-line" rating on the stock in a research note on Wednesday, July 9th. Finally, Robert W. Baird cut their target price on Agilon Health from $5.00 to $1.00 and set a "neutral" rating on the stock in a research note on Thursday, August 14th. Four analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $3.07.

Check Out Our Latest Stock Report on Agilon Health

Agilon Health Stock Up 7.7%

The company's 50-day moving average is $1.86 and its two-hundred day moving average is $2.99. The company has a market cap of $549.11 million, a P/E ratio of -1.72 and a beta of 0.14.

Agilon Health (NYSE:AGL - Get Free Report) last released its earnings results on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14). Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. The company had revenue of $1.39 billion during the quarter, compared to analysts' expectations of $1.47 billion. During the same quarter in the previous year, the firm earned ($0.07) earnings per share. The firm's revenue was down 5.9% compared to the same quarter last year. On average, analysts anticipate that Agilon Health, Inc. will post -0.59 EPS for the current fiscal year.

Institutional Trading of Agilon Health

Large investors have recently bought and sold shares of the company. Wells Fargo & Company MN lifted its position in shares of Agilon Health by 47.5% during the 4th quarter. Wells Fargo & Company MN now owns 144,763 shares of the company's stock valued at $275,000 after buying an additional 46,645 shares during the last quarter. Russell Investments Group Ltd. raised its stake in Agilon Health by 6,931.3% in the 4th quarter. Russell Investments Group Ltd. now owns 36,141 shares of the company's stock valued at $69,000 after acquiring an additional 35,627 shares during the period. Cerity Partners LLC bought a new stake in Agilon Health in the 4th quarter valued at about $34,000. Renaissance Technologies LLC lifted its holdings in Agilon Health by 155.1% during the fourth quarter. Renaissance Technologies LLC now owns 463,300 shares of the company's stock valued at $880,000 after purchasing an additional 281,700 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in Agilon Health during the fourth quarter worth about $33,000.

About Agilon Health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Should You Invest $1,000 in Agilon Health Right Now?

Before you consider Agilon Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.

While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 High Short Interest Stocks to Buy Before November
HUGE Upside Ahead: The Fastest Growing ETFs in the Market
Next Tech Boom: AI Robots Are Coming Sooner Than You Think!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines